Literature DB >> 20618465

UVA1 phototherapy: a review of mechanism and therapeutic application.

Nathan R York1, Heidi T Jacobe.   

Abstract

Ultraviolet radiation (UVR) phototherapy has been associated with both deleterious and beneficial effects to patients with both localized and systemic skin disorders. Phototherapy is advantageous in diseases of the epidermis and dermis, as it provides the most direct approach minimizing systemic side effects. Most recently, ultraviolet A1 (UVA1) phototherapy has emerged as a specific UVR phototherapeutic mechanism. It has shown to be therapeutic in a number of sclerosing skin conditions and other dermatitides, in many cases proving to be more effective than other phototherapy modalities. Treatment advantages of UVA1 phototherapy include the ability to penetrate into the deep layers of the skin to affect changes on disease-causing T cells, as well as activation of endothelial cells to promote neovascularization. UVA1 therapy also has been shown to be relatively free of side effects associated with other phototherapy regimens, including erythema and cellular transformation. These properties make UVA1 phototherapy an important treatment option for many debilitating skin conditions.

Entities:  

Mesh:

Year:  2010        PMID: 20618465     DOI: 10.1111/j.1365-4632.2009.04427.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  17 in total

1.  UVA1 phototherapy in the treatment of palmoplantar pustulosis: a pilot prospective study.

Authors:  Li-Na Su; Xin Xu; Li Tang; Ning Yu; Yang-Feng Ding
Journal:  Lasers Med Sci       Date:  2016-07-20       Impact factor: 3.161

2.  UVA1 vs. narrowband UVB phototherapy in the treatment of palmoplantar pustulosis: a pilot randomized controlled study.

Authors:  Li-Na Su; Jie Ren; Shi-Meng Cheng; Jian-Lan Liu; Yang-Feng Ding; Ning-Wen Zhu
Journal:  Lasers Med Sci       Date:  2017-07-11       Impact factor: 3.161

3.  'High dose' vs. 'medium dose' UVA1 phototherapy in italian patients with severe atopic dermatitis.

Authors:  A Pacifico; P Iacovelli; G Damiani; C Ferraro; S Cazzaniga; R R Z Conic; G Leone; A Morrone
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-12-28       Impact factor: 6.166

4.  Efficacy assessment of UVA1 and narrowband UVB for treatment of scalp psoriasis.

Authors:  Jing Zhou; Xuemei Yi; Ying Li; Yangfeng Ding
Journal:  Lasers Med Sci       Date:  2018-06-18       Impact factor: 3.161

5.  Fractional carbon dioxide laser versus low-dose UVA-1 phototherapy for treatment of localized scleroderma: a clinical and immunohistochemical randomized controlled study.

Authors:  S M Shalaby; M Bosseila; M M Fawzy; D M Abdel Halim; S S Sayed; R S H M Allam
Journal:  Lasers Med Sci       Date:  2016-08-10       Impact factor: 3.161

Review 6.  Ultraviolet Radiation in Wound Care: Sterilization and Stimulation.

Authors:  Asheesh Gupta; Pinar Avci; Tianhong Dai; Ying-Ying Huang; Michael R Hamblin
Journal:  Adv Wound Care (New Rochelle)       Date:  2013-10       Impact factor: 4.730

7.  Interventions for chronic pruritus of unknown origin.

Authors:  Andrea Andrade; Chii Yang Kuah; Juliana Esther Martin-Lopez; Shunjie Chua; Volha Shpadaruk; Gloria Sanclemente; Juan Va Franco
Journal:  Cochrane Database Syst Rev       Date:  2020-01-25

Review 8.  The role of dendritic cells and regulatory T cells in the pathogenesis of morphea.

Authors:  Agnieszka Osmola-Mańkowska; Ewa Teresiak-Mikołajczak; Aleksandra Dańczak-Pazdrowska; Michał Kowalczyk; Ryszard Żaba; Zygmunt Adamski
Journal:  Cent Eur J Immunol       Date:  2015-04-22       Impact factor: 2.085

9.  Diversity of biological effects induced by longwave UVA rays (UVA1) in reconstructed skin.

Authors:  Claire Marionnet; Cécile Pierrard; Christelle Golebiewski; Françoise Bernerd
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

Review 10.  Immune Cell-Stromal Circuitry in Lupus Photosensitivity.

Authors:  Ji Hyun Sim; William G Ambler; Isabel F Sollohub; Mir J Howlader; Thomas M Li; Henry J Lee; Theresa T Lu
Journal:  J Immunol       Date:  2021-01-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.